Condition category
Cancer
Date applied
23/01/2004
Date assigned
23/01/2004
Last edited
22/05/2012
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Prof Jessica Corner

ORCID ID

Contact details

The Institute of Cancer Research
The Centre for Cancer and Palliative Care Studies
Royal Cancer Hospital
Fulham Road
London
SW3 6JJ
United Kingdom
+44 (0)20 7352 8171

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

NCP/J17/18

Study information

Scientific title

Acronym

Study hypothesis

Not provided at time of registration

Ethics approval

Not provided at time of registration

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Hospitals

Trial type

Treatment

Patient information sheet

Not available in web format, please use the contact details below to request a patient information sheet

Condition

Cancer (neoplasms): Lung (non-small cell)

Intervention

1. Conventional medical follow-up:
At the specialist cancer hospital, patients were seen within one month and, if stable, discharged back to their referring cancer unit. At the cancer units, follow-up was 2 - 3 monthly if patients were stable. At all centres, patients who were not considered medically stable were seen on the basis of need.
2. Nurse-led follow-up:
Patients allocated to one of two Clinical Nurse Specialists (CNS) who took responsibility for their follow-up care for one year. Patients assessed monthly or on basis of need by telephone or at a nurse-led clinic. Patients could also use a paging system to contact CNS if they had concerns during intervals between assessments. Focus of care was not only disease surveillance but also the physical, psychological and social needs of patients and their families. Emphasis on prompt communication and liaison with primary care teams. Patients attended hospital medical clinics only if their condition indicated this was needed or if patients requested a consultation with a hospital physician.

Intervention type

Other

Phase

Not Specified

Drug names

Primary outcome measures

Not provided at time of registration

Secondary outcome measures

Not provided at time of registration

Overall trial start date

01/01/1999

Overall trial end date

01/01/2001

Reason abandoned

Eligibility

Participant inclusion criteria

1. Patients with lung cancer having completed initial treatment
2. Not requiring immediate medical intervention or close medical supervision
3. Considered to have a good performance status (World Health Organization [WHO] performance status 0 - 2)
4. Had an expected prognosis of at least 3 months
5. Were not participating in other clinical trials requiring intensive medical investigation or follow-up
6. Understood and read English for informed consent and data collection purposes

Participant type

Patient

Age group

Not Specified

Gender

Not Specified

Target number of participants

Not provided at time of registration

Participant exclusion criteria

Not provided at time of registration

Recruitment start date

01/01/1999

Recruitment end date

01/01/2001

Locations

Countries of recruitment

United Kingdom

Trial participating centre

The Institute of Cancer Research
London
SW3 6JJ
United Kingdom

Sponsor information

Organisation

Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)

Sponsor details

The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Sponsor type

Government

Website

http://www.doh.gov.uk

Funders

Funder type

Government

Funder name

NHS Cancer National Research and Development Programme (UK)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Results in http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12433764

Publication citations

  1. Results

    Moore S, Corner J, Haviland J, Wells M, Salmon E, Normand C, Brada M, O'Brien M, Smith I, Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial., BMJ, 2002, 325, 7373, 1145.

Additional files

Editorial Notes